(Automated) Synthesis of Well-defined Staphylococcus Aureus Wall Teichoic Acid Fragments.
antibodies
automated synthesis
gram-positive bacteria
ribitol phosphate
wall teichoic acids
Journal
Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783
Informations de publication
Date de publication:
16 Jul 2021
16 Jul 2021
Historique:
received:
07
04
2021
pubmed:
16
5
2021
medline:
21
7
2021
entrez:
15
5
2021
Statut:
ppublish
Résumé
Wall teichoic acids (WTAs) are important components of the cell wall of the opportunistic Gram-positive bacterium Staphylococcus aureus. WTAs are composed of repeating ribitol phosphate (RboP) residues that are decorated with d-alanine and N-acetyl-d-glucosamine (GlcNAc) modifications, in a seemingly random manner. These WTA-modifications play an important role in shaping the interactions of WTA with the host immune system. Due to the structural heterogeneity of WTAs, it is impossible to isolate pure and well-defined WTA molecules from bacterial sources. Therefore, here synthetic chemistry to assemble a broad library of WTA-fragments, incorporating all possible glycosylation modifications (α-GlcNAc at the RboP C4; β-GlcNAc at the RboP C4; β-GlcNAc at the RboP C3) described for S. aureus WTAs, is reported. DNA-type chemistry, employing ribitol phosphoramidite building blocks, protected with a dimethoxy trityl group, was used to efficiently generate a library of WTA-hexamers. Automated solid phase syntheses were used to assemble a WTA-dodecamer and glycosylated WTA-hexamer. The synthetic fragments have been fully characterized and diagnostic signals were identified to discriminate the different glycosylation patterns. The different glycosylated WTA-fragments were used to probe binding of monoclonal antibodies using WTA-functionalized magnetic beads, revealing the binding specificity of these WTA-specific antibodies and the importance of the specific location of the GlcNAc modifications on the WTA-chains.
Identifiants
pubmed: 33991006
doi: 10.1002/chem.202101242
pmc: PMC8361686
doi:
Substances chimiques
Teichoic Acids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10461-10469Subventions
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 91713303
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 09150181910001
Informations de copyright
© 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.
Références
Org Lett. 2018 Aug 3;20(15):4449-4452
pubmed: 30028624
Bioorg Med Chem. 2016 Sep 1;24(17):3893-3907
pubmed: 26993744
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E576-85
pubmed: 25624472
Org Biomol Chem. 2014 Feb 28;12(8):1184-97
pubmed: 24382624
Microbiol Mol Biol Rev. 2003 Dec;67(4):686-723
pubmed: 14665680
Org Lett. 2012 Feb 3;14(3):848-51
pubmed: 22264133
Nature. 2018 Nov;563(7733):705-709
pubmed: 30464342
Infect Immun. 2015 Nov;83(11):4247-55
pubmed: 26283333
Chemistry. 2018 Mar 15;24(16):4014-4018
pubmed: 29389054
MAbs. 2018 Oct;10(7):979-991
pubmed: 30102105
PLoS One. 2014 Oct 21;9(10):e110953
pubmed: 25333799
PLoS Pathog. 2016 Dec 14;12(12):e1006067
pubmed: 27973583
Chem Sci. 2013 Aug 1;4(8):2995-3008
pubmed: 25893089
Clin Infect Dis. 2012 Feb 15;54(4):560-7
pubmed: 22186773
Carbohydr Res. 2006 Sep 4;341(12):2037-48
pubmed: 16458277
Nature. 2019 Aug;572(7767):E1-E2
pubmed: 31367020
Bioorg Med Chem. 2010 Jun 1;18(11):3668-78
pubmed: 20409722
Chem Soc Rev. 2017 Mar 6;46(5):1464-1482
pubmed: 27990523
Genome Biol. 2017 Jul 20;18(1):130
pubmed: 28724393
Carbohydr Res. 2012 Jul 15;356:142-51
pubmed: 22429772
N Engl J Med. 1998 Aug 20;339(8):520-32
pubmed: 9709046
Chemistry. 2021 Jul 16;27(40):10461-10469
pubmed: 33991006